Betterise Health Tech

Betterise Health Tech developed CE-marked medical software platforms to monitor and support patients at home through real-life data analysis. Their solutions have been deployed across multiple therapeutic areas including oncology, cardiology, urology, diabetes management, pregnancy care/prevention services. The company’s technology enables early detection of complications or toxicities related to therapies and provides personalized therapeutic follow-up. Their products are certified under ISO13485/ISO27001 standards with a focus on security and regulatory compliance. In November 2021 the company was acquired by Resilience to strengthen its offering in remote patient monitoring—especially cancer care—and continues as part of the Resilience group.